New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - clopamide 20mg - tablet - 20 mg - active: clopamide 20mg

Ireland - English - HPRA (Health Products Regulatory Authority)

novartis pharmaceuticals uk ltd - clopamide - tablets

Ireland - English - HPRA (Health Products Regulatory Authority)

novartis pharmaceuticals uk ltd - clopamide potassium chloride potassium bicarbonate docusate sodium - tablets effervescent

Canada - English - Health Canada

mylan pharmaceuticals ulc - pindolol - tablet - 5mg - pindolol 5mg - beta-adrenergic blocking agents

Canada - English - Health Canada

mylan pharmaceuticals ulc - pindolol - tablet - 10mg - pindolol 10mg - beta-adrenergic blocking agents

India - English - Central Drugs Standard Control Organization

novartis - clopamide - tab - 20mg - 10

United States - English - NLM (National Library of Medicine)

takeda pharmaceuticals america, inc. - vortioxetine hydrobromide (unii: tks641koay) (vortioxetine - unii:3o2k1s3wqv) - vortioxetine 5 mg - brintellix is indicated for the treatment of major depressive disorder (mdd). the efficacy of brintellix was established in six 6 to 8 week studies (including one study in the elderly) and one maintenance study in adults [see clinical studies (14)] . pregnancy category c risk summary there are no adequate and well-controlled studies of brintellix in pregnant women. vortioxetine caused developmental delays when administered during pregnancy to rats and rabbits at doses 15 and 10 times the maximum recommended human dose (mrhd) of 20 mg, respectively. developmental delays were also seen after birth in rats at doses 20 times the mrhd of vortioxetine given during pregnancy and through lactation. there were no teratogenic effects in rats or rabbits at doses up to 77 and 58 times, the mrhd of vortioxetine, respectively, given during organogenesis. the incidence of malformations in human pregnancies has not been established for brintellix. all human pregnancies, regardless of drug exposure, have a background rate of

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

lundbeck ltd - vortioxetine hydrobromide - tablet - 5mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

lundbeck ltd - vortioxetine hydrobromide - tablet - 20mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

lundbeck ltd - vortioxetine hydrobromide - tablet - 10mg